A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging

The Translocase of Outer Mitochondrial Membrane 40 Homolog and Apolipoprotein E (TOMM40-APOE) locus has been associated with a number of age-related phenotypes in humans including nonpathologic cognitive aging, late-onset Alzheimer's disease, and longevity. Here, we investigate the influence of the TOMM40 intron 6 poly-T variant (rs10524523) on TOMM40 gene expression and cognitive abilities and decline in a cohort of 1613 community-dwelling elderly volunteers who had been followed for changes in cognitive functioning over a period of 14 years (range = 12-18 years). We showed that the shorter length poly-T variants were found to act as a repressor of luciferase gene expression in reporter gene constructs. Expression was reduced to approximately half of that observed for the very long variant. We further observed that the shorter poly-T variant was significantly associated with reduced vocabulary ability and a slower rate of vocabulary decline with age compared to the very long poly-T variants. No significant associations were observed for memory, fluid intelligence or processing speed, although the direction of effect, where the short variant was correlated with reduced ability and slower rate of decline was observed for all tests. Our results indicate that the poly-T variant has the ability to interact with transcription machinery and differentially modulate reporter gene expression and influence vocabulary ability and decline with age.

[1]  David M Holtzman,et al.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.

[2]  TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer’s Disease , 2012, Translational Stroke Research.

[3]  Krzysztof Safranow,et al.  TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity. , 2012, Journal of Alzheimer's disease : JAD.

[4]  M. Horan,et al.  The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age, 1983 through 2003 , 2004, Cognitive Development and the Ageing Process.

[5]  Jennifer A. Erwin,et al.  Mobile DNA elements in the generation of diversity and complexity in the brain , 2014, Nature Reviews Neuroscience.

[6]  Paul K Crane,et al.  Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. , 2012, Archives of neurology.

[7]  Lorna M. Lopez,et al.  Genome-wide association studies establish that human intelligence is highly heritable and polygenic , 2011, Molecular Psychiatry.

[8]  R. Corbo,et al.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? , 1999, Annals of human genetics.

[9]  J. V. Moran,et al.  Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells , 2011, Proceedings of the National Academy of Sciences.

[10]  M. Batzer,et al.  5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome. , 2009, Genome research.

[11]  K. Kasai,et al.  Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia , 2014, Neuron.

[12]  Robert C. Green,et al.  The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype , 2011, Alzheimer's & Dementia.

[13]  A. Roses,et al.  A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging , 2012, Alzheimer's & Dementia.

[14]  Lorna M. Lopez,et al.  A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing , 2014, Molecular Psychiatry.

[15]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[16]  N. Mayo,et al.  Older women's health priorities and perceptions of care delivery: results of the WOW health survey , 2005, Canadian Medical Association Journal.

[17]  R. Löwer,et al.  The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery , 2011, Nucleic acids research.

[18]  A. Roses,et al.  The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes , 2014, European Neuropsychopharmacology.

[19]  J. Mattick,et al.  Somatic retrotransposition alters the genetic landscape of the human brain , 2011, Nature.

[20]  J. Quinn,et al.  SVA retrotransposons as modulators of gene expression , 2014, Mobile genetic elements.

[21]  L. Bekris,et al.  Functional Analysis of APOE Locus Genetic Variation Implicates Regional Enhancers in the Regulation of Both TOMM40 and APOE , 2011, Journal of Human Genetics.

[22]  Howard Hu,et al.  Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. , 2012, Journal of Alzheimer's disease : JAD.

[23]  I. Deary,et al.  The neuroscience of human intelligence differences , 2010, Nature Reviews Neuroscience.

[24]  G. Breen,et al.  Characterisation of the potential function of SVA retrotransposons to modulate gene expression patterns , 2013, BMC Evolutionary Biology.

[25]  A. Roses,et al.  TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial , 2013, Alzheimer's & Dementia.

[26]  I. Deary,et al.  Alzheimer’s Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936 , 2013, PloS one.

[27]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[28]  G. Breen,et al.  An Evaluation of a SVA Retrotransposon in the FUS Promoter as a Transcriptional Regulator and Its Association to ALS , 2014, PloS one.

[29]  Guojun Bu,et al.  ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners? , 2014, Neuron.

[30]  D. Stojanovski,et al.  Dissection of the Mitochondrial Import and Assembly Pathway for Human Tom40* , 2005, Journal of Biological Chemistry.

[31]  S. Lovestone,et al.  UK Alzheimer's Disease Genetics Consortium , 1999, International journal of geriatric psychiatry.

[32]  N. Ghebranious,et al.  Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology , 2005, Nucleic acids research.

[33]  J. Dubnau,et al.  Transposable Elements in TDP-43-Mediated Neurodegenerative Disorders , 2012, PloS one.

[34]  A. Roses,et al.  Genetic variation at a single locus and age of onset for Alzheimer's disease , 2010, Alzheimer's & Dementia.

[35]  A. Roses,et al.  Longitudinal modeling of cognitive aging and the TOMM40 effect , 2012, Alzheimer's & Dementia.

[36]  A. Comas-Herrera,et al.  Cognitive impairment in older people: future demand for long‐term care services and the associated costs , 2007, International journal of geriatric psychiatry.

[37]  Russell H. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: An update , 2009, Experimental Neurology.

[38]  A. Roses,et al.  Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations , 2012, PloS one.